436 Trastuzumab- (H) and everolimus- (RAD001) containing regimens are safe and active when reintroduced in patients (pts) with HER2-overexpressing metastatic breast cancer (MBC) pre-treated with lapatinib

✍ Scribed by M. Campone; L. Gianni; C. Massacesi; C. Manlius; R. O'Regan; F. Dalenc; L. Vittori; Y. Zhang; T. Sahmoud; F. Andre

• Book ID: 119601443
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 46 KB
• Volume: 8
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(10)70458-4